Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.430
-0.010 (-0.69%)
At close: Dec 5, 2025, 4:00 PM EST
1.490
+0.060 (4.20%)
After-hours: Dec 5, 2025, 7:22 PM EST
Sunshine Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -5.99 | -5.13 | -4.51 | -26.74 | -12.44 | -2.78 | Upgrade
|
| Depreciation & Amortization | 0.3 | 0.22 | 0.15 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.62 | - | - | 18.33 | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.01 | - | - | 0.92 | 0.05 | Upgrade
|
| Other Operating Activities | - | - | - | -0.01 | 9.79 | 2.11 | Upgrade
|
| Change in Accounts Receivable | -1.17 | -2.34 | -0.59 | -0.52 | -0.01 | -0 | Upgrade
|
| Change in Inventory | -4.21 | -6.01 | -2.37 | 0.04 | -0.08 | -0.01 | Upgrade
|
| Change in Accounts Payable | 2.13 | 3.98 | -1.36 | 3.36 | -0.02 | -0.04 | Upgrade
|
| Change in Income Taxes | 0.07 | -0.81 | -0.07 | 0.24 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.14 | -2.46 | -0.02 | 0.03 | -0 | 0 | Upgrade
|
| Operating Cash Flow | -7.13 | -12.53 | -8.78 | -5.25 | -1.83 | -0.66 | Upgrade
|
| Capital Expenditures | -0.28 | -1.66 | -0.08 | -0.19 | - | -0 | Upgrade
|
| Cash Acquisitions | - | - | - | -14.35 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.62 | -0.32 | -0.71 | -0.11 | - | - | Upgrade
|
| Other Investing Activities | -0.34 | -0.34 | 0.13 | 0.03 | - | - | Upgrade
|
| Investing Cash Flow | -1.23 | -2.32 | -0.66 | -14.62 | - | -0 | Upgrade
|
| Long-Term Debt Issued | - | 0.35 | - | - | 3.32 | 1.67 | Upgrade
|
| Total Debt Issued | 0.35 | 0.35 | - | - | 3.32 | 1.67 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.13 | -1.93 | -0.48 | -0.11 | Upgrade
|
| Total Debt Repaid | - | - | -0.13 | -1.93 | -0.48 | -0.11 | Upgrade
|
| Net Debt Issued (Repaid) | 0.35 | 0.35 | -0.13 | -1.93 | 2.84 | 1.57 | Upgrade
|
| Issuance of Common Stock | 5.64 | 12.08 | 4.09 | 43.56 | - | - | Upgrade
|
| Repurchase of Common Stock | - | -3.14 | -0.54 | -0.1 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -2.06 | 0.06 | 0.04 | Upgrade
|
| Financing Cash Flow | 5.99 | 9.29 | 3.43 | 39.47 | 2.9 | 1.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.54 | -1.04 | 0.47 | 0.18 | -0.02 | -0 | Upgrade
|
| Net Cash Flow | -2.9 | -6.61 | -5.53 | 19.78 | 1.06 | 0.95 | Upgrade
|
| Free Cash Flow | -7.4 | -14.19 | -8.86 | -5.44 | -1.83 | -0.66 | Upgrade
|
| Free Cash Flow Margin | -19.84% | -40.68% | -36.76% | -125.24% | -800.75% | -922.13% | Upgrade
|
| Free Cash Flow Per Share | -2.13 | -20.22 | -690.63 | - | - | - | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | - | 0.05 | 0.04 | 0.02 | Upgrade
|
| Cash Income Tax Paid | - | 0.58 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -6.5 | -12.39 | -8.2 | -4.35 | -0.91 | -0.44 | Upgrade
|
| Unlevered Free Cash Flow | -6.5 | -12.38 | -8.12 | -4.33 | -0.7 | -0.34 | Upgrade
|
| Change in Working Capital | -3.05 | -7.63 | -4.42 | 3.15 | -0.11 | -0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.